Pixium Vision SA, Second Sight Medical Products, Inc. - M&A Call Transcript
Hello. Good morning, good evening, everyone. Welcome to this video conference, Pixium Vision and Second Sight. And on behalf of both teams, I'd like to wish you all a happy and healthy 2021.
Next slide. I would like you to take note of our forward-looking statement provisions and legal disclaimer.
Next slide. On the call with us today, we have -- I have 3 other colleagues with me, Matt Pfeffer, who is the CEO of Second Sight; Guillaume Renondin, who is the CFO of Pixium Vision; and Professor José-Alain Sahel, who is the distinguished Professor and Chair of the Department of Ophthalmology at the University of Pittsburgh School of Medicine.
We would like to take the next 30 minutes to present to you more information and detail around the news that we announced this morning, collectively between Pixium Vision and Second Sight. And then at the end of the 30 minutes, we'll be happy to entertain any questions that you can certainly pose by typing them in the question box.
Next slide. So perhaps a word about the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
